United States Rivaroxaban Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Rivaroxaban

Revenue, means the sales value of Rivaroxaban

This report studies sales (consumption) of Rivaroxaban in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Rivaroxaban in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Rivaroxaban Market Report 2016

Table of Contents
United States Rivaroxaban Market Report 2016
1 Rivaroxaban Overview
1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Rivaroxaban
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Rivaroxaban (2011-2021)
1.4.1 United States Rivaroxaban Sales and Growth Rate (2011-2021)
1.4.2 United States Rivaroxaban Revenue and Growth Rate (2011-2021)
2 United States Rivaroxaban Competition by Manufacturers
2.1 United States Rivaroxaban Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Rivaroxaban Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Rivaroxaban Average Price by Manufactures (2015 and 2016)
2.4 Rivaroxaban Market Competitive Situation and Trends
2.4.1 Rivaroxaban Market Concentration Rate
2.4.2 Rivaroxaban Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Rivaroxaban Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Rivaroxaban Sales and Market Share by Type (2011-2016)
3.2 United States Rivaroxaban Revenue and Market Share by Type (2011-2016)
3.3 United States Rivaroxaban Price by Type (2011-2016)
3.4 United States Rivaroxaban Sales Growth Rate by Type (2011-2016)
4 United States Rivaroxaban Sales (Volume) by Application (2011-2016)
4.1 United States Rivaroxaban Sales and Market Share by Application (2011-2016)
4.2 United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Rivaroxaban Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Rivaroxaban Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Rivaroxaban Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Rivaroxaban Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Rivaroxaban Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Rivaroxaban Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Rivaroxaban Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Rivaroxaban Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Rivaroxaban Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Rivaroxaban Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Rivaroxaban Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Rivaroxaban Manufacturing Cost Analysis
6.1 Rivaroxaban Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Rivaroxaban
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Rivaroxaban Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Rivaroxaban Market Forecast (2016-2021)
10.1 United States Rivaroxaban Sales, Revenue Forecast (2016-2021)
10.2 United States Rivaroxaban Sales Forecast by Type (2016-2021)
10.3 United States Rivaroxaban Sales Forecast by Application (2016-2021)
10.4 Rivaroxaban Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Rivaroxaban
Table Classification of Rivaroxaban
Figure United States Sales Market Share of Rivaroxaban by Type in 2015
Table Application of Rivaroxaban
Figure United States Sales Market Share of Rivaroxaban by Application in 2015
Figure United States Rivaroxaban Sales and Growth Rate (2011-2021)
Figure United States Rivaroxaban Revenue and Growth Rate (2011-2021)
Table United States Rivaroxaban Sales of Key Manufacturers (2015 and 2016)
Table United States Rivaroxaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rivaroxaban Sales Share by Manufacturers
Figure 2016 Rivaroxaban Sales Share by Manufacturers
Table United States Rivaroxaban Revenue by Manufacturers (2015 and 2016)
Table United States Rivaroxaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Rivaroxaban Revenue Share by Manufacturers
Table 2016 United States Rivaroxaban Revenue Share by Manufacturers
Table United States Market Rivaroxaban Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Rivaroxaban Average Price of Key Manufacturers in 2015
Figure Rivaroxaban Market Share of Top 3 Manufacturers
Figure Rivaroxaban Market Share of Top 5 Manufacturers
Table United States Rivaroxaban Sales by Type (2011-2016)
Table United States Rivaroxaban Sales Share by Type (2011-2016)
Figure United States Rivaroxaban Sales Market Share by Type in 2015
Table United States Rivaroxaban Revenue and Market Share by Type (2011-2016)
Table United States Rivaroxaban Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Type (2011-2016)
Table United States Rivaroxaban Price by Type (2011-2016)
Figure United States Rivaroxaban Sales Growth Rate by Type (2011-2016)
Table United States Rivaroxaban Sales by Application (2011-2016)
Table United States Rivaroxaban Sales Market Share by Application (2011-2016)
Figure United States Rivaroxaban Sales Market Share by Application in 2015
Table United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
Figure United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Rivaroxaban Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Rivaroxaban Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Rivaroxaban Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure United States Rivaroxaban Production and Growth Rate Forecast (2016-2021)
Figure United States Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Table United States Rivaroxaban Production Forecast by Type (2016-2021)
Table United States Rivaroxaban Consumption Forecast by Application (2016-2021)
  • Global Duchenne Muscular Dystrophy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Apr-2018        Price: US 3480 Onwards        Pages: 104
    Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, resp......
  • Global Foam Dressing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Apr-2018        Price: US 3480 Onwards        Pages: 109
    A Foam Dressing, consists of sterile polyurethane foam, hydrocolloid adhesive (polystyrene, sodium carboxymethyl cellulose, etc.), which is an opaque polyurethane dressing that is permeable to vapors but partially occlusive to liquids. It is typically used to cover wounds over bony ridges or near inflamed skin, especially in burns, open wounds, pressure ulcers,venous ulcers, diabetic, etc. Scope of the Report: This report focuses on the Foam Dressing in global marke......
  • Global Infusion Pharmacy Management Market by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Apr-2018        Price: US 3480 Onwards        Pages: 101
    Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective. Infusion Pharmacy includes infusion of antibiotic, antifungal, antiviral, pain management and nutritional drug through needle or catheter. Diseases such as cancer, diabetes, gastrointestinal disorder and pain related disorders are generally treated with infusion medication system. Infusion pharmacy can also be administered in home by providing doorstep services. Home infusion ph......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Disposable Ostomy Bags Market 2018 Forecast to 2023
    Published: 17-Apr-2018        Price: US 4880 Onwards        Pages: 103
    Disposable?Ostomy?Bags is a?prosthetic?medical device?that provides a means for the collection of waste from a surgically diverted biological system (colon,?ileum,?bladder) and the creation of a?stoma. Pouching systems are most commonly associated with?colostomies,?ileostomies, and urostomies. Scope of the Report: This report focuses on the Disposable Ostomy Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and A......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Donepezil Market 2018 Forecast to 2023
    Published: 17-Apr-2018        Price: US 4880 Onwards        Pages: 103
    Donepezil is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease. Scope of the Report: This report focuses on the Donepezil in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and app......
  • Global Interferon Alpha-2a Biosimilar Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Apr-2018        Price: US 3480 Onwards        Pages: 101
    Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences. Scope of the Report: This report focuses on the Interferon Alpha-2a Biosimilar in global market, especia......
  • Global Ligament Stabilizer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Apr-2018        Price: US 3480 Onwards        Pages: 103
    This report studies the Ligament Stabilizer market, the ligament stabilizer includes the knee braces & supports, foot and ankle braces & supports, shoulder braces & supports, spinal orthoses and wrist & hand braces & supports. Scope of the Report: This report focuses on the Ligament Stabilizer in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions,......
  • Global Medical Asparaginase Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-Apr-2018        Price: US 3480 Onwards        Pages: 101
    Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Scope of the Report: This report focuses on the Medical Asparaginase in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the mark......
  • EMEA (Europe, Middle East and Africa) Embolization Particle Market 2017 Forecast to 2022
    Published: 11-Apr-2018        Price: US 4480 Onwards        Pages: 118
    Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. Scope of the Report: This report focuses on the Embolization Particle in EMEA market, covering......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs